Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
QIPT
Upturn stock ratingUpturn stock rating

Quipt Home Medical Corp (QIPT)

Upturn stock ratingUpturn stock rating
$2
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/06/2025: QIPT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

5 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $3.4

1 Year Target Price $3.4

Analysts Price Target For last 52 week
$3.4Target price
Low$1.35
Current$2
high$4.07

Analysis of Past Performance

Type Stock
Historic Profit -58.11%
Avg. Invested days 19
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/06/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 79.79M USD
Price to earnings Ratio -
1Y Target Price 3.4
Price to earnings Ratio -
1Y Target Price 3.4
Volume (30-day avg) 5
Beta 0.17
52 Weeks Range 1.35 - 4.07
Updated Date 06/30/2025
52 Weeks Range 1.35 - 4.07
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.21

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.6%
Operating Margin (TTM) -1.67%

Management Effectiveness

Return on Assets (TTM) -0.32%
Return on Equity (TTM) -8.1%

Valuation

Trailing PE -
Forward PE 56.82
Enterprise Value 160946046
Price to Sales(TTM) 0.33
Enterprise Value 160946046
Price to Sales(TTM) 0.33
Enterprise Value to Revenue 0.67
Enterprise Value to EBITDA 3.27
Shares Outstanding 43444000
Shares Floating 34533179
Shares Outstanding 43444000
Shares Floating 34533179
Percent Insiders 15.27
Percent Institutions 56.1

Analyst Ratings

Rating 3
Target Price 3.4
Buy 1
Strong Buy 3
Buy 1
Strong Buy 3
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Quipt Home Medical Corp

stock logo

Company Overview

overview logo History and Background

Quipt Home Medical Corp. was founded in 2015 and has grown through acquisitions and organic growth to become a provider of durable medical equipment (DME) and respiratory care solutions.

business area logo Core Business Areas

  • Durable Medical Equipment (DME): Supplies a wide range of DME, including mobility aids, hospital beds, and other medical equipment for home use.
  • Respiratory Care: Provides respiratory equipment and supplies, including oxygen concentrators, ventilators, and CPAP/BiPAP machines.
  • Home Medical Supplies: Offers a variety of medical supplies used in the home, such as wound care products, incontinence supplies, and personal hygiene items.

leadership logo Leadership and Structure

The leadership team includes Greg Crawford (Chairman & CEO), Hardik Mehta (CFO). The organizational structure is hierarchical, with various departments responsible for different aspects of the business.

Top Products and Market Share

overview logo Key Offerings

  • Oxygen Concentrators: Provides oxygen concentrators for patients with respiratory conditions. Competitors: Inogen (INGN), ResMed (RMD). Revenue contribution is significant, part of respiratory segment which contributes around 45% to overall revenue.
  • CPAP/BiPAP Machines: Offers CPAP/BiPAP machines for sleep apnea treatment. Market Share for CPAP/BiPAP market is fragmented with ResMed (RMD), Philips Respironics being major competitors. Revenue contribution significant, part of respiratory segment which contributes around 45% to overall revenue.
  • Mobility Equipment: Provides mobility equipment like wheelchairs and walkers. Competitors: Permobil, Pride Mobility Products. The DME segment contributes about 55% of total revenue.

Market Dynamics

industry overview logo Industry Overview

The DME and respiratory care market is growing due to the aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. Market is highly fragmented with national and regional players.

Positioning

Quipt Home Medical Corp. is positioned as a consolidator in the fragmented DME market, focusing on acquisitions and organic growth to expand its market share. They have a competitive advantage in excellent customer service.

Total Addressable Market (TAM)

The US home medical equipment market is estimated to be $60 billion. Quipt is positioned to capture more of the market through acquisitions and expansion of its services.

Upturn SWOT Analysis

Strengths

  • Strong acquisition strategy
  • Recurring revenue model
  • Geographic diversification
  • Strong cash flow generation
  • Excellent customer service

Weaknesses

  • High debt levels due to acquisitions
  • Integration risks with acquisitions
  • Dependence on reimbursement rates
  • Susceptibility to competitive pressures
  • Reliance on key personnel

Opportunities

  • Further acquisitions in a fragmented market
  • Expansion of product and service offerings
  • Growth in telehealth and remote patient monitoring
  • Increased demand for home-based healthcare
  • Growing aging population.

Threats

  • Changes in government reimbursement policies
  • Increased competition from larger players
  • Rising interest rates
  • Economic downturn
  • Supply chain disruptions.

Competitors and Market Share

competitor logo Key Competitors

  • RMD
  • INGN
  • HME

Competitive Landscape

Quipt Home Medical Corp. competes with larger, more established players in the DME and respiratory care market. The company differentiates itself through its customer service and acquisition strategy.

Major Acquisitions

NorCal Respiratory Services, Inc.

  • Year: 2023
  • Acquisition Price (USD millions): 10.7
  • Strategic Rationale: Enhances the Companyu2019s respiratory care presence in the Northern California region.

Lake Medical Equipment

  • Year: 2024
  • Acquisition Price (USD millions): 5.5
  • Strategic Rationale: Expands Quipt's footprint and strengthens its respiratory care capabilities, and establishes a strong presence in a key geographic area.

Growth Trajectory and Initiatives

Historical Growth: Quipt Home Medical Corp. has experienced rapid growth through acquisitions and organic expansion. Revenue has increased significantly over the past few years.

Future Projections: Analysts project continued growth in revenue and earnings, driven by further acquisitions and expansion of existing operations.

Recent Initiatives: Recent initiatives include the acquisition of new DME providers, expansion of respiratory care services, and investment in technology to improve operational efficiency.

Summary

Quipt Home Medical Corp. is a rapidly growing DME and respiratory care provider with a strong acquisition strategy and a recurring revenue model. The company faces challenges related to high debt levels and reimbursement pressures, but it is well-positioned to capitalize on the growing demand for home-based healthcare. Quipt needs to continue improving operational efficiency while focusing on integrating acquired companies effectively. Managing government reimbursement risks is also essential for sustained growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Analyst reports
  • Industry publications

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It should not be considered investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Quipt Home Medical Corp

Exchange NASDAQ
Headquaters Wilder, KY, United States
IPO Launch date 2021-05-27
Chairman, President & CEO Mr. Gregory J. Crawford
Sector Healthcare
Industry Medical Distribution
Full time employees 1200
Full time employees 1200

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.